Literature DB >> 20644061

The Bradford Hill criteria and zinc-induced anosmia: a causality analysis.

Terence M Davidson1, Wendy M Smith.   

Abstract

OBJECTIVE: To apply the Bradford Hill criteria, which are widely used to establish causality between an environmental agent and disease, to evaluate the relationship between over-the-counter intranasal zinc gluconate therapy and anosmia.
DESIGN: Patient and literature review applying the Bradford Hill criteria on causation.
SETTING: University of California, San Diego, Nasal Dysfunction Clinic. PATIENTS: The study included 25 patients who presented to the University of California, San Diego, Nasal Dysfunction Clinic complaining of acute-onset anosmia after intranasal application of homeopathic zinc gluconate gel. MAIN OUTCOME MEASURES: Each of the 9 Bradford Hill criteria--strength of association, consistency, specificity, temporality, biological gradient (dose-response), biological plausibility, biological coherence, experimental evidence, and analogy--was applied to intranasal zinc gluconate therapy and olfactory dysfunction using published, peer-reviewed medical literature and reported clinical experiences.
RESULTS: Clinical, biological, and experimental data support the Bradford Hill criteria to demonstrate that intranasal zinc gluconate therapy causes hyposmia and anosmia.
CONCLUSIONS: The Bradford Hill criteria represent an important tool for scientifically determining cause between environmental exposure and disease. Increased Food and Drug Administration oversight of homeopathic medications is needed to monitor the safety of these popular remedies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644061     DOI: 10.1001/archoto.2010.111

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  15 in total

Review 1.  The role of metals in mammalian olfaction of low molecular weight organosulfur compounds.

Authors:  Eric Block; Victor S Batista; Hiroaki Matsunami; Hanyi Zhuang; Lucky Ahmed
Journal:  Nat Prod Rep       Date:  2017-05-10       Impact factor: 13.423

2.  Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria.

Authors:  Manfred Hauben; Stephen Bai; Eric Hung; Kasia Lobello; Charles Tressler; Vincent P Zucal
Journal:  Eur J Clin Pharmacol       Date:  2021-01-07       Impact factor: 2.953

3.  Management of Smell Dysfunction.

Authors:  Livije Kalogjera; Davor Dzepina
Journal:  Curr Allergy Asthma Rep       Date:  2012-02-02       Impact factor: 4.806

Review 4.  Testing the validity of preventing chronic regional pain syndrome with vitamin C after distal radius fracture. [Corrected].

Authors:  Sunitha Malay; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2014-09-16       Impact factor: 2.230

5.  A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease.

Authors:  Michael H Rosenbloom; Terry R Barclay; Maria Pyle; Brian L Owens; Amanda B Cagan; Christopher P Anderson; William H Frey; Leah R Hanson
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

6.  Human sinonasal explant system for testing cytotoxicity of intranasal agents.

Authors:  Jae H Lim; Greg E Davis; Tessa C Rue; Daniel R Storm
Journal:  Int Forum Allergy Rhinol       Date:  2011-12-13       Impact factor: 3.858

7.  Mechanistic studies of the toxicity of zinc gluconate in the olfactory neuronal cell line Odora.

Authors:  Heidi Hsieh; Kavitha Subramanian Vignesh; George S Deepe; Divaker Choubey; Howard G Shertzer; Mary Beth Genter
Journal:  Toxicol In Vitro       Date:  2016-05-12       Impact factor: 3.500

Review 8.  Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunities.

Authors:  Vidyasagar Chinni; John El-Khoury; Marlon Perera; Rinaldo Bellomo; Daryl Jones; Damien Bolton; Joseph Ischia; Oneel Patel
Journal:  Br J Clin Pharmacol       Date:  2021-06-02       Impact factor: 3.716

9.  Metal concentrations and distributions in the human olfactory bulb in Parkinson's disease.

Authors:  Bronwen Gardner; Birger V Dieriks; Steve Cameron; Lakshini H S Mendis; Clinton Turner; Richard L M Faull; Maurice A Curtis
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

Review 10.  Causality Assessment of Olfactory and Gustatory Dysfunction Associated with Intranasal Fluticasone Propionate: Application of the Bradford Hill Criteria.

Authors:  Chandrashekhar S Muganurmath; Amy L Curry; Andrew H Schindzielorz
Journal:  Adv Ther       Date:  2018-02-02       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.